[MAYBANK] YoY TTM Result on 30-Sep-2008 [#1]

Announcement Date
11-Nov-2008
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2009
Quarter
30-Sep-2008 [#1]
Profit Trend
QoQ- -5.58%
YoY- -17.34%
View:
Show?
TTM Result
31/03/12 31/03/11 30/09/09 30/09/08 30/09/07 30/09/06 30/09/05 CAGR
Revenue 26,405,682 20,055,958 18,419,000 13,782,085 15,561,305 13,161,985 11,912,723 13.01%
PBT 7,194,193 5,901,032 1,948,732 3,953,742 4,506,967 3,932,296 3,648,169 11.00%
Tax -1,893,202 -1,559,463 -862,022 -1,132,607 -1,088,058 -1,176,649 -1,012,969 10.09%
NP 5,300,991 4,341,569 1,086,710 2,821,135 3,418,909 2,755,647 2,635,200 11.34%
-
NP to SH 5,088,249 4,208,436 1,001,504 2,764,946 3,345,120 2,682,754 2,620,432 10.74%
-
Tax Rate 26.32% 26.43% 44.24% 28.65% 24.14% 29.92% 27.77% -
Total Cost 21,104,691 15,714,389 17,332,290 10,960,950 12,142,396 10,406,338 9,277,523 13.46%
-
Net Worth 34,012,756 29,884,116 25,955,863 19,941,107 19,455,794 17,738,551 17,214,872 11.03%
Dividend
31/03/12 31/03/11 30/09/09 30/09/08 30/09/07 30/09/06 30/09/05 CAGR
Div 5,087,797 5,118,987 507,668 1,560,458 3,770,000 1,897,473 5,628,527 -1.54%
Div Payout % 99.99% 121.64% 50.69% 56.44% 112.70% 70.73% 214.79% -
Equity
31/03/12 31/03/11 30/09/09 30/09/08 30/09/07 30/09/06 30/09/05 CAGR
Net Worth 34,012,756 29,884,116 25,955,863 19,941,107 19,455,794 17,738,551 17,214,872 11.03%
NOSH 7,639,711 7,324,358 7,077,070 4,882,022 3,891,158 3,801,742 3,726,162 11.67%
Ratio Analysis
31/03/12 31/03/11 30/09/09 30/09/08 30/09/07 30/09/06 30/09/05 CAGR
NP Margin 20.08% 21.65% 5.90% 20.47% 21.97% 20.94% 22.12% -
ROE 14.96% 14.08% 3.86% 13.87% 17.19% 15.12% 15.22% -
Per Share
31/03/12 31/03/11 30/09/09 30/09/08 30/09/07 30/09/06 30/09/05 CAGR
RPS 345.64 273.83 260.26 282.30 399.91 346.21 319.70 1.20%
EPS 66.60 57.46 14.15 56.64 85.97 70.57 70.33 -0.83%
DPS 66.60 69.89 7.17 31.96 97.50 50.00 151.05 -11.83%
NAPS 4.4521 4.0801 3.6676 4.0846 5.00 4.6659 4.62 -0.56%
Adjusted Per Share Value based on latest NOSH - 4,882,022
31/03/12 31/03/11 30/09/09 30/09/08 30/09/07 30/09/06 30/09/05 CAGR
RPS 218.83 166.21 152.64 114.21 128.96 109.07 98.72 13.01%
EPS 42.17 34.88 8.30 22.91 27.72 22.23 21.72 10.73%
DPS 42.16 42.42 4.21 12.93 31.24 15.72 46.64 -1.54%
NAPS 2.8187 2.4765 2.151 1.6525 1.6123 1.47 1.4266 11.03%
Price Multiplier on Financial Quarter End Date
31/03/12 31/03/11 30/09/09 30/09/08 30/09/07 30/09/06 30/09/05 CAGR
Date 30/03/12 31/03/11 30/09/09 30/09/08 28/09/07 29/09/06 30/09/05 -
Price 8.87 8.96 6.65 6.90 11.00 11.20 11.60 -
P/RPS 2.57 3.27 2.56 2.44 2.75 3.24 3.63 -5.17%
P/EPS 13.32 15.59 46.99 12.18 12.80 15.87 16.49 -3.22%
EY 7.51 6.41 2.13 8.21 7.82 6.30 6.06 3.35%
DY 7.51 7.80 1.08 4.63 8.86 4.46 13.02 -8.11%
P/NAPS 1.99 2.20 1.81 1.69 2.20 2.40 2.51 -3.50%
Price Multiplier on Announcement Date
31/03/12 31/03/11 30/09/09 30/09/08 30/09/07 30/09/06 30/09/05 CAGR
Date 24/05/12 12/05/11 12/11/09 11/11/08 15/11/07 14/11/06 17/11/05 -
Price 8.50 8.74 6.84 5.50 11.40 11.50 11.00 -
P/RPS 2.46 3.19 2.63 1.95 2.85 3.32 3.44 -5.02%
P/EPS 12.76 15.21 48.33 9.71 13.26 16.30 15.64 -3.08%
EY 7.84 6.57 2.07 10.30 7.54 6.14 6.39 3.19%
DY 7.83 8.00 1.05 5.81 8.55 4.35 13.73 -8.27%
P/NAPS 1.91 2.14 1.86 1.35 2.28 2.46 2.38 -3.32%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment